HSPLANT Stock Overview
Hap Seng Plantations Holdings Berhad, an investment holding company, operates as an oil palm plantation company in Malaysia.
Hap Seng Plantations Holdings Berhad Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||RM2.37|
|52 Week High||RM3.50|
|52 Week Low||RM1.77|
|1 Month Change||-14.44%|
|3 Month Change||-9.54%|
|1 Year Change||31.67%|
|3 Year Change||48.13%|
|5 Year Change||-9.20%|
|Change since IPO||-22.55%|
Recent News & Updates
Analysts Just Shipped A Substantial Upgrade To Their Hap Seng Plantations Holdings Berhad (KLSE:HSPLANT) Estimates
Celebrations may be in order for Hap Seng Plantations Holdings Berhad ( KLSE:HSPLANT ) shareholders, with the analysts...
|HSPLANT||MY Food||MY Market|
Return vs Industry: HSPLANT exceeded the MY Food industry which returned -1.8% over the past year.
Return vs Market: HSPLANT exceeded the MY Market which returned -8.7% over the past year.
|HSPLANT Average Weekly Movement||5.7%|
|Food Industry Average Movement||5.0%|
|Market Average Movement||5.5%|
|10% most volatile stocks in MY Market||11.5%|
|10% least volatile stocks in MY Market||2.9%|
Stable Share Price: HSPLANT is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: HSPLANT's weekly volatility (6%) has been stable over the past year.
About the Company
Hap Seng Plantations Holdings Berhad, an investment holding company, operates as an oil palm plantation company in Malaysia. The company engages in the cultivation of oil palm; and processing of fresh fruit bunches into crude palm oil. As of December 31, 2021, it had a total planted area of 35,434 hectares.
Hap Seng Plantations Holdings Berhad Fundamentals Summary
|HSPLANT fundamental statistics|
Is HSPLANT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HSPLANT income statement (TTM)|
|Cost of Revenue||RM373.08m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.37|
|Net Profit Margin||37.43%|
How did HSPLANT perform over the long term?See historical performance and comparison
7.2%Current Dividend Yield
Is HSPLANT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HSPLANT?
Other financial metrics that can be useful for relative valuation.
|What is HSPLANT's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does HSPLANT's PE Ratio compare to its peers?
|HSPLANT PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
BPLANT Boustead Plantations Berhad
KMLOONG Kim Loong Resources Berhad
FAREAST Far East Holdings Berhad
TSH TSH Resources Berhad
HSPLANT Hap Seng Plantations Holdings Berhad
Price-To-Earnings vs Peers: HSPLANT is good value based on its Price-To-Earnings Ratio (6.4x) compared to the peer average (7.8x).
Price to Earnings Ratio vs Industry
How does HSPLANT's PE Ratio compare vs other companies in the MY Food Industry?
Price-To-Earnings vs Industry: HSPLANT is good value based on its Price-To-Earnings Ratio (6.4x) compared to the MY Food industry average (12.2x)
Price to Earnings Ratio vs Fair Ratio
What is HSPLANT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||6.4x|
|Fair PE Ratio||8.6x|
Price-To-Earnings vs Fair Ratio: HSPLANT is good value based on its Price-To-Earnings Ratio (6.4x) compared to the estimated Fair Price-To-Earnings Ratio (8.6x).
Share Price vs Fair Value
What is the Fair Price of HSPLANT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HSPLANT (MYR2.37) is trading below our estimate of fair value (MYR3.52)
Significantly Below Fair Value: HSPLANT is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: HSPLANT's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Discover undervalued companies
How is Hap Seng Plantations Holdings Berhad forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSPLANT's earnings are forecast to decline over the next 3 years (-35.9% per year).
Earnings vs Market: HSPLANT's earnings are forecast to decline over the next 3 years (-35.9% per year).
High Growth Earnings: HSPLANT's earnings are forecast to decline over the next 3 years.
Revenue vs Market: HSPLANT's revenue is expected to decline over the next 3 years (-17% per year).
High Growth Revenue: HSPLANT's revenue is forecast to decline over the next 3 years (-17% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HSPLANT's Return on Equity is forecast to be low in 3 years time (6.3%).
Discover growth companies
How has Hap Seng Plantations Holdings Berhad performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HSPLANT has high quality earnings.
Growing Profit Margin: HSPLANT's current net profit margins (37.4%) are higher than last year (25.8%).
Past Earnings Growth Analysis
Earnings Trend: HSPLANT's earnings have grown by 18.2% per year over the past 5 years.
Accelerating Growth: HSPLANT's earnings growth over the past year (135.8%) exceeds its 5-year average (18.2% per year).
Earnings vs Industry: HSPLANT earnings growth over the past year (135.8%) exceeded the Food industry 35.1%.
Return on Equity
High ROE: HSPLANT's Return on Equity (15.9%) is considered low.
Discover strong past performing companies
How is Hap Seng Plantations Holdings Berhad's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: HSPLANT's short term assets (MYR619.7M) exceed its short term liabilities (MYR60.7M).
Long Term Liabilities: HSPLANT's short term assets (MYR619.7M) exceed its long term liabilities (MYR414.7M).
Debt to Equity History and Analysis
Debt Level: HSPLANT is debt free.
Reducing Debt: HSPLANT has not had any debt for past 5 years.
Debt Coverage: HSPLANT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: HSPLANT has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Hap Seng Plantations Holdings Berhad current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: HSPLANT's dividend (7.17%) is higher than the bottom 25% of dividend payers in the MY market (2.15%).
High Dividend: HSPLANT's dividend (7.17%) is in the top 25% of dividend payers in the MY market (4.94%)
Stability and Growth of Payments
Stable Dividend: HSPLANT's dividend payments have been volatile in the past 10 years.
Growing Dividend: HSPLANT's dividend payments have fallen over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.9%), HSPLANT's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (66.2%), HSPLANT's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Edward Lee (66 yo)
Datuk-Ming Foo Lee, also known as Edward, JP, has been the Managing Director of Hap Seng Consolidated Berhad (“HSCB”) since March 31, 2005. Datuk Lee has been the Managing Director of Hap Seng Plantations...
CEO Compensation Analysis
Compensation vs Market: Edward's total compensation ($USD198.68K) is below average for companies of similar size in the MY market ($USD333.71K).
Compensation vs Earnings: Edward's compensation has been consistent with company performance over the past year.
Experienced Board: HSPLANT's board of directors are considered experienced (5.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Hap Seng Plantations Holdings Berhad's employee growth, exchange listings and data sources
- Name: Hap Seng Plantations Holdings Berhad
- Ticker: HSPLANT
- Exchange: KLSE
- Founded: 1946
- Industry: Agricultural Products
- Sector: Food, Beverage & Tobacco
- Implied Market Cap: RM1.855b
- Shares outstanding: 799.69m
- Website: https://www.hapsengplantations.com.my
Number of Employees
- Hap Seng Plantations Holdings Berhad
- Menara Hap Seng
- 21st Floor
- Kuala Lumpur
- Wilayah Persekutuan
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/27 00:00|
|End of Day Share Price||2022/06/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.